KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.37.

  • Bionano Genomics' Asset Utilization Ratio rose 2041.33% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year increase of 2041.33%. This contributed to the annual value of 0.21 for FY2024, which is 5279.23% up from last year.
  • Bionano Genomics' Asset Utilization Ratio amounted to 0.37 in Q3 2025, which was up 2041.33% from 0.36 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Asset Utilization Ratio registered a high of 0.38 during Q4 2024, and its lowest value of 0.04 during Q2 2021.
  • Over the past 5 years, Bionano Genomics' median Asset Utilization Ratio value was 0.11 (recorded in 2023), while the average stood at 0.17.
  • As far as peak fluctuations go, Bionano Genomics' Asset Utilization Ratio plummeted by 9020.49% in 2021, and later soared by 12763.33% in 2024.
  • Bionano Genomics' Asset Utilization Ratio (Quarter) stood at 0.05 in 2021, then surged by 80.48% to 0.09 in 2022, then surged by 106.9% to 0.18 in 2023, then soared by 105.88% to 0.38 in 2024, then dropped by 1.29% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.36 for Q2 2025, and 0.37 during Q1 2025.